BBG just reported that big pharma, armed with big $, is actively targeting smaller firms to bolster their pipelines and revs. This sort of catalyst may just add more fuel to the fire for Qcor. And stating the obvious, Q is way undervalued and may be considered low hanging fruit to Big Pharma desperate for growth. The wind is at Q's back now...all they have to do is continue executing their strategy. Q is embedded with numerous catalysts and the Big Pharma angle is just another, but possibly significant catalyst.